The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps

NCT05131464 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Interventions

DRUG: CM310

Sponsor

Keymed Biosciences Co.Ltd